Although the correlation between decreased GSDME levels and tumor size, clinical stage, age, or tumor recurrence rate in NSCLC patients was no significance, however, NSCLC patients with lower GSDME expression had shorter survival times, higher mortality rate, and lower degree of T-cell infiltration after platinum treatment (57). Here, GSDME is linked to neoplasm.